The hype surrounding diabetes and weight loss injections is driving up Swiss healthcare costs. "The expenditure for all health insurers in Switzerland will amount to several hundred million francs next year,” says Philomena Colatrella, head of the CSS insurer. Check out our selection of newsletters. Subscribe here. In an interview with the Tages-Anzeiger newspaper published online on Tuesday, Colatrella said that CSS estimates the cost of the appetite suppressant Wegovy alone at over CHF50 million next year. It is not yet known whether other therapy costs will fall in return. The long-term consequences are also not yet clear. "What we are seeing is a very strong increase in volumes." A country comparison with the United states, Germany and Canada showed that Switzerland has the highest per capita use of fat-loss injections, according to a study published on Monday in the specialist journal JAMA Internal Medicine. Switzerland is one of the few countries where the cost of the ...
